Revolution Medicines to Participate in November 2026 Investor Conferences
Revolution Medicines announced CEO and chairman Mark A. Goldsmith will participate in two November investor conferences. He will appear in fireside chats at the 3rd Annual Guggenheim Healthcare Innovation Conference on November 10 and the Jefferies Global Healthcare Conference in London on November 16, both webcast live.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.